• Username (E-mail)
  • Password
Dow 19,827 0.5%  EStoxx50 3,299 0.3%  Nikkei 19,138 0.3%  EUR 1.0702 0.4% 
Nasdaq 5,555 0.3%  FTSE100 7,198 -0.1%  Yen 114.6250 0.0%  Oil 55.5 2.4% 
S&P500 2,271 0.3%  DAX 11,630 0.3%  GBP 1.2380 0.4%  Gold 1,214 -0.5% 

Cree share [Symbol: CREE / ISIN: US2254471012]

07/03/2012 02:27:19 AM
07/03/2012 02:27:19 AM UTC-0400

Cree Inc. Underperform

The analysts of Banc of America Securities-Merrill Lynch have rated Cree with a Underperform rating. The price target was set to 17.00 $. At a current price of the Cree stock of 28.05 $ this means a downside potential of -39.39%.
Summary: Cree Inc. Underperform
Company:
Cree Inc.
Analyst:
Banc of America Securities-Merrill Lynch
Price Target:
17.00 $
Current Rating:
Underperform
Price*:
25.22 $
Distance to Target Price*:
-32.59%
Previous Rating:
new coverage
Latest Price:
28.05 $
Distance Price Target:
-39.39%
Analyst Name::
-
P/E Ratio*:
-

Analyst Opinions for Cree Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
12/21/16
Cree Goldman Sachs Group Inc.
08/17/16
Cree Goldman Sachs Group Inc.
10/01/13
Cree Goldman Sachs Group Inc.
12/06/12
Cree D.A. Davidson & Co.
11/30/12
Cree Deutsche Bank Securities

Add or Edit Instrument

Related Stocks

Cree Inc. 28.05 1.54% Cree Inc.
Latest Analyst Opinions
01/20/17 Nemetschek Commerzbank AG
01/20/17 HeidelbergCement DZ BANK
01/20/17 Apple Macquarie Research
01/20/17 Microsoft Goldman Sachs Group Inc.
01/20/17 Diageo Goldman Sachs Group Inc.
01/20/17 Reckitt Benckiser Group Goldman Sachs Group Inc.
01/20/17 Tate & Lyle Goldman Sachs Group Inc.
01/20/17 Software Oddo Seydler Bank AG
01/20/17 Unilever Goldman Sachs Group Inc.
01/20/17 Unilever Goldman Sachs Group Inc.
01/20/17 Ahold Delhaize Goldman Sachs Group Inc.
01/20/17 LVMH Moet Hennessy Louis Vuitton Goldman Sachs Group Inc.
01/20/17 Uniper Barclays Capital
01/20/17 TAG Immobilien Morgan Stanley
01/20/17 Banco Santander Central Hispano UBS AG
01/20/17 Vivendi Goldman Sachs Group Inc.
01/20/17 Wirecard Commerzbank AG
01/20/17 Scout24 Commerzbank AG
01/20/17 RHÖN-KLINIKUM Commerzbank AG
01/20/17 OSRAM Licht Commerzbank AG
01/20/17 Continental Morgan Stanley
01/20/17 Volvo (B) Morgan Stanley
01/20/17 Renault Morgan Stanley
01/20/17 Peugeot Morgan Stanley
01/20/17 Volkswagen vz Morgan Stanley
01/20/17 Daimler Morgan Stanley
01/20/17 BMW Morgan Stanley
01/20/17 KION GROUP Morgan Stanley
01/20/17 Linde Warburg Research
01/20/17 Pfeiffer Vacuum Technology Warburg Research
01/20/17 Intesa Sanpaolo Kepler Cheuvreux
01/20/17 SAFRAN Kepler Cheuvreux
01/20/17 Walmart Stifel, Nicolaus & Co., Inc.
01/20/17 RHÖN-KLINIKUM Baader Bank
01/20/17 CANCOM Baader Bank
01/20/17 Capital Stage Oddo Seydler Bank AG
01/20/17 WACKER CHEMIE Hauck & Aufhäuser Privatbankiers KGaA
01/20/17 CompuGroup Medical HSBC
01/20/17 Infineon Technologies Commerzbank AG
01/20/17 Hornbach Commerzbank AG
01/20/17 SAFRAN UBS AG
01/20/17 Banco Bilbao Vizcaya Argentaria UBS AG
01/20/17 Compagnie de Saint-Gobain Deutsche Bank AG
01/20/17 Aurubis Deutsche Bank AG
01/20/17 ASML Deutsche Bank AG
01/20/17 Ahold Delhaize Deutsche Bank AG
01/20/17 Commerzbank Deutsche Bank AG
01/20/17 Deutsche Post Jefferies & Company Inc.
01/20/17 Banco Santander Central Hispano Jefferies & Company Inc.
01/20/17 Sanofi Jefferies & Company Inc.